3188 results for «872»
3188 results
New evidence for treatment of calcified coronary artery disease
20 May 2025 – From EuroPCR 2025
Explore the latest randomized trials and studies advancing the treatment of calcified coronary artery disease. This session covers cutting balloon use, lithotripsy versus conventional preparation, and one-year outcomes comparing rotational atherectomy, lithotripsy, and laser. Also highlighted is the EMPOWER CAD study focusing on women treated with...
How to deal with secondary mitral regurgitation in 2025?
20 May 2025 – From EuroPCR 2025
Delve into the evolving management of secondary mitral regurgitation, and the critical role of the Heart Team. This session replay presents the latest clinical trials, treatment guidelines, and a case-based discussion covering medical and interventional strategies, heart failure optimization, frailty assessment, and advanced imaging techniques.
Valve-in-valve and coronary protection
11 Sep 2025 – From PCR Rio Valves 2025
Explore complex valve-in-valve procedures and coronary protection strategies through a series of challenging case presentations. Topics include management of high-risk valve-in-valve scenarios, strategies for degenerated aortic bioprostheses, innovative transcarotid approaches, fenestration stenting for late coronary obstruction, and analysis of valve embolisation events, providing valuable insights for...
Novelties on how to manage difficult TAVI situations
11 Sep 2025 – From PCR Rio Valves 2025
Stay at the forefront of TAVI management with this session highlighting novel approaches to difficult clinical scenarios. Topics include predictive scoring for pacemaker implantation, impact of baseline frailty on recovery, comparative imaging for coronary stenosis evaluation, physiology-guided PCI in TAVI patients, and outcomes of extrathoracic non-transfemoral...
Tailored transfemoral TAVI in complex anatomies - LIVE Case
11 Sep 2025 – From PCR Rio Valves 2025
Supported by an unrestricted educational grant from Medtronic
An 89-year-old male with hypertension, dyslipidemia, current smoking, stage III kidney disease, and a history of diagonal PCI in 2010 presented with severe symptomatic aortic stenosis and a small annulus (410 mm²), with RBBB on ECG.
Via bilateral femoral access,...
Mitral valve - How to evaluate?
11 Sep 2025 – From PCR Rio Valves 2025
This educational session focuses on comprehensive evaluation of the mitral valve to guide clinical decision-making. Topics include risk stratification and patient selection for Mitral TEER, detailed anatomy review, assessment of primary and secondary mitral regurgitation phenotypes, advanced quantification techniques per current guidelines, and pre-intervention transoesophageal echocardiography...
Angiography-derived fractional flow reserve versus intravascular ultrasound to guide percutaneous coronary intervention in patients with coronary artery disease: the FLAVOUR II trial
29 Mar 2025
Ali Nazmi Calik provides his take on the FLAVOUR II trial presented by Jian-An Wang at ACC.25 in Chicago.
Author
The AQUATIC trial: Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation
01 Sep 2025
Chiara De Biase provides her take on the results of AQUATIC presented by Martine Gilard at ESC Congress 2025 in Madrid.
Author
![The AQUATIC trial [Assessment of quitting versus using aspirin therapy in patients with stabilized coronary artery disease after stenting who require long-term oral anticoagulation: Rationale for and design of the AQUATIC double-blind randomized trial]](https://www.pcronline.com/var/pcrov3/storage/images/pcronline/news/congress-coverages/esc/2025/aquatic-trial-quitting-versus-using-aspirin-therapy-patients-stabilized-cad-stenting-long-term-oral-anticoagulation/27448089-9-eng-GB/The-AQUATIC-trial-Assessment-of-quitting-versus-using-aspirin-therapy-in-patients-with-stabilized-coronary-artery-disease-after-stenting-who-requi_image_responsive_6.jpg)